Credivera announced today that it has expanded its service offerings to their customers through collaboration with BTNX Inc. (“BTNX”), a biotechnology company and world leader in rapid, diagnostic testing solutions. BTNX will integrate with Credivera’s Digital Wallet and display verified results of rapid drug and alcohol screens, and COVID-19 antigen rapid testing.
Dan Giurescu, Chief Executive Officer of Credivera commented, “The ability for our customers in high-compliance, regulated industries to add these verified health credentials to their digital Wallets, adds additional confidence and convenience when demonstrating fit for work capability. Together with BTNX, we are helping make worksites safer and more efficient when deploying talent.”
BTNX’s products—distributed by Lochness Medical Supplies Inc. (“Lochness Medical”) in the USA—have an international reach serving clinics, staffing agencies, and laboratories across the globe. As companies seek to provide proof of a drug-free work environment, BTNX offers a variety of testing products, with a shelf life of two years, a much-needed solution for remote and rural worksites.
“In the digital age the merger of technology and diagnostics is fast becoming a necessity in the staffing and employment industry and the ability to rapidly connect tests results with verified employee credentials will set industry leaders apart.” shared Iqbal Sunderani, BTNX founder and CEO.
When an individual conducts a rapid drug and alcohol screen, or COVID-19 test, the results are visible in 15 minutes or less (depending on the product). Using BTNX’s Rapid Reader App the results are then sent to the individual and the site manager, from there the individual can add their results to their Credivera Wallet and meet the testing requirements of their employer. The company can immediately see who complies or needs to be replaced by another worker.
To learn more about using digital verified credentials to achieve workforce compliance, contact Credivera to request a demonstration of the Credivera Wallet and BTNX’s RapidReader application.
Based in Ontario, Canada, BTNX Inc. is a biotechnology company with an international reputation for excellence earned through consistently delivering value and quality over its 21 years in business as a Canadian Manufacturer of diagnostic products. Under the Rapid Response® brand, BTNX offers a comprehensive range of rapid point-of-care diagnostic tests. BTNX’s Rapid Response® products are distributed by Lochness Medical Supplies Inc. in the USA. Together BTNX and Lochness Medical provide their customers with the highest quality products at competitive pricing. This is accomplished through partnering with innovative manufacturing facilities staffed with teams of experts, allowing BTNX and Lochness Medical. to deliver real value to their customers. Learn more at www.btnx.com and www.lochnessmedical.com.
Credivera is the world’s first secure, open exchange for verifiable credentials. A leader in workforce management and digital identity, Credivera gives employees, employers, and organizations that issue credentials increased productivity and control of how important credentials are stored and shared. The Credivera Exchange optimizes personal privacy and trust, with up-to-date verifiable credentials secured in a digital wallet, resulting in reduced risk for all. Founded in 2017, with offices in Toronto and Calgary, Credivera supports regulated industries and global technology firms in over 30 countries worldwide. Get more out of what you know at credivera.com.